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Graphical abstract:
Abstract: A synthetic pathway towards gem-difluorinated cyclohexane β-amino acids, involving
regio- and stereoselective hydroxylation, C=C reduction, alcohol oxidation, and deoxofluorination,
described earlier has been considerably improved. Across Pd-catalyzed double-bond migration, the
intermediate allylic alcohols are directly and efficiently transformed into the corresponding
saturated ketones. To extend this improved method, the synthesis of new cyclic β-amino acid
derivatives with an allylic alcohol motif was attempted using organoselenium chemistry.
Keywords: β-amino acids, deoxofluorination, double bond migration, oxidative deselenylation,
selenocyclization
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Introduction
Although fluorine-containing organic compounds are rare in nature [1], they are more and
more common in pharmaceutical chemistry [2-5]. The reasons behind the advance of fluorinated
drugs are the benefits of fluorination, which originate in the unique properties of the fluorine atom
and  the carbon–fluorine bond. First of all, because of its small size, the fluorine atom can be used
for isosteric replacement of hydrogens, hydroxyl groups or methoxy groups. Importantly, fluorine
incorporation can efficiently suppress oxidative metabolism. This is because C–F bonds are
stronger than C–H bonds, and the very high electronegativity of fluorine decreases electron density
of the surrounding atoms. Fluorine incorporation makes nearby functional groups more acidic,
shifting the ratio of charged and neutral drug species. Together with the interesting polar
hydrophobic nature of the C–F motif, this shift affects lipophilicity. The fluorine atom of C–F
bonds with partial negative charge can also create new attractive electrostatic interactions with
target molecules [2,5,6].
From the viewpoint of medicinal chemistry, amino acids are of high importance [7-20].
Within this highly diverse compound family, cyclic β-amino acids have received more and more
attention in the last decades [9-13,20]. These compounds can be found as subunits in bioactive
natural compounds like blasticidin S (1), amipurimycin (2), gougerotin, and chryscandin
(Scheme 1) [9,10,21]. Many small-molecule β-amino acid derivatives, including natural products
cispentacin (3) and oxetin as well as synthetic compounds icofungipen and tilidin (4), also possess
biological activity (Scheme 1) [9,10]. A rather promising application of cyclic β-amino acids is the


































Scheme 1. Bioactive β-amino acid derivatives.
Since both organofluorine compounds and amino acids are of high importance, fluorinated
amino acid derivatives have received increasing attention. The most studied compound families are
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fluorinated acyclic or cyclic α-amino acids and fluorinated acyclic β-amino acids [14-19]. Since
fluorinated cyclic β-amino acids are scarcely studied [19-20], we focused on the synthesis of these
compounds and developed a considerable number of synthetic pathways towards fluorinated cyclic
β-amino acid derivatives in the last decade [22-37].
Results
In our earlier reports, we reported the synthesis of gem-difluorinated cyclohexane β-amino
acid derivatives from cyclohexene β-amino acids (±)-5 and (±)-14 via regio- and stereoselective
hydroxylation, C=C reduction, alcohol oxidation, and deoxofluorination (Schemes 2 and 3)
[22,23,38]. The synthesis of gem-difluorinated cyclopentane β-amino acid derivative (±)-37 from
cyclopentene β-amino acids (±)-26 and (±)-27 was accomplished in a slightly different pathway
(Scheme 4) [26].
Scheme 2. Original synthesis of 3,3-difluorinated cyclohexane β-amino esters (ref. [22]).
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Scheme 3. Original synthesis of 5,5-difluorinated cyclohexane β-amino esters (ref. [23]).
Scheme 4. Original synthesis of gem-difluorinated cyclopentane β-amino ester (±)-37 (ref. [26]).
We realized, however, that these methods have some problematic issues. In the pathways
depicted on Schemes 2 and 3, redox-neutral processes (transformations of allylic alcohols (±)-8,
(±)-9, (±)-20, and (±)-21 to ketones (±)-10, (±)-11, (±)-22, and (±)-23)  were  performed  in  two
subsequent steps. This approach is not completely optimal from an economical viewpoint. Namely,
the pathway depicted on Scheme 4 uses stoichiometric amounts of toxic tributyltin hydride and
hazardous pyridinium chlorochromate (PCC).
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Our aim was to eliminate the above weaknesses as much as possible. First, this directed our
attention to transition-metal catalyzed direct transformation of allylic alcohols to ketones. This
simple, atom-economic process is based on ring C=C bond isomerization of the substrate to afford
an enol intermediate, which tautomerizes to the more stable oxo form (Figure 1). The driving force
of the transformation is the higher strength of the C=O bond compared to that of the C=C bond.
Such reactions were mostly achieved via homogenous catalysis, but the successful use of
heterogeneous catalysts, such as Pd/C [39], Pd/TiO2 [40], Pd/Al2O3 [41-42] or Pd nanoparticles
[43], was also reported. Additional benefits are easy handling and separation of heterogeneous
catalysts. Therefore, we decided to attempt redox isomerization of allylic alcohols using Pd/C.
Possible side reactions are reduction of the substrate C=C bond or the product C=O bond.
Consequently, a careful selection of reaction conditions was needed to maximize the yield of the
desired product.
Figure 1. Direct transformation of allylic alcohols to ketones via C=C migration.
Our first model substrate was allylic alcohol derivative (±)-8. After some attempts, some
modifications of the conditions, e.g., changing the solvent from EtOH to EtOAc and increasing the
reaction time, were sufficient to shift the reaction towards redox isomerization, and product (±)-10
was isolated in 89% yield (Scheme 5). Notably, the original two-step (±)-8 → (±)-10 transformation
gave only a 55% overall product yield. The analogous transformation of compound (±)-9 to ketone
(±)-11 was also successful (Scheme 5). The isolated yield of 92% compares favorably with 59% of
the two-step process. Next, keto esters (±)-10 and (±)-11 were converted. According to a slightly
modified procedure, treatment with Deoxofluor in CH2Cl2 at room temperature in 12 h delivered the
corresponding difluorinated derivatives (±)-12 and (±)-13 (Scheme 5).
Scheme 5. One-step redox isomerization of allylic alcohols (±)-8 and (±)-9
to the corresponding keto derivatives.
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Redox isomerization of allylic alcohols (±)-20 and (±)-21 was also successful (Scheme 6)
affording much higher yields than those in the original protocol [(±)-20 → (±)-22: 64% (original
two steps) vs. 91% (current protocol); (±)-21 → (±)-23: 63% (original two steps) vs. 90% (new
method)]. Both oxo esters (±)-22 and (±)-23 were easily transformed across deoxofluorination into
the desired difluorinated products (±)-24 and (±)-25 (Scheme 6).
Scheme 6. One-step redox isomerization of allylic alcohols (±)-20 and (±)-21 to keto derivatives.
To extend this new method, we aimed to synthesize other cyclic β-amino esters with allylic
alcohol moieties. Unfortunately, subjecting oxazolidinone (±)-30 to HI elimination/heteroring
opening (see Schemes 2 and 3) failed, because neither tBuOK nor DBU was able to induce
elimination of HI. Treatment of (±)-30 with KOH in THF/H2O provided unexpected product (±)-39
via carbamate ring opening and SN2 substitution of iodide (Scheme 7). Notably, in an earlier study,



















Scheme 7. Reactions of iodooxazolidinone (±)-30 with bases.
In order to solve the elimination problems, we turned to organoselenium chemistry. PhSe+
can take part in similar electrophilic processes as I+, and it can be eliminated under mild oxidative
conditions (e.g., with H2O2) [45-47]. Treatment of cyclopentene β-amino esters with PhSeBr had an
outcome depending on the protecting group. From N-benzoylated (±)-40, selenooxazoline
derivative (±)-41 was formed, while carbamate protecting groups (especially Boc) led to the
formation of selenooxazolidinone (±)-44. N-Boc protection of compound (±)-44 followed by
oxidative deselenylation under basic conditions [47] yielded the desired product (±)-38 (Scheme 8).
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Scheme 8. Selenocyclizations of cis cyclopentene β-amino esters.
Unfortunately, all attempts to open the heteroring of (±)-38 with ethoxide resulted in
decomposition with the formation of unidentifiable polymeric materials.
Analogous transformations of N-Boc-protected trans aminoester (±)-27 afforded unsaturated
oxazolidinone (±)-49 (Scheme 9). In addition to NMR analysis, the structure of intermediate (±)-48
was confirmed by its X-ray crystal structure (Figure 2). Details of its structure determination are
presented in Experimental Section. Similar to its stereoisomer (±)-38, subjecting (±)-49 to ethoxide
treatment resulted in decomposition instead of heteroring opening.
Scheme 9. Selenocyclization of trans cyclopentene β-amino ester (±)-27.
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Figure 2. Crystal structure of selenooxazolidinone (±)-48.
Next, we applied the selenocyclization/N-protection/oxidative deselenylation sequence to
cyclohexene β-amino ester (±)-51. Unexpectedly, the oxidation led to the formation of highly
unsaturated ester (±)-55. The most plausible explanation is a base-promoted E1cb elimination of the
desired product (±)-54 (Scheme 10). Decomposition of (±)-38 and (±)-49 upon treatment with the
strongly basic ethoxide can be explained with similar E1cb elimination processes (the resulting
highly reactive α,β,γ,δ-unsaturated esters easily undergo polymerization).
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Scheme 10. Selenocyclization of cyclohexene β-amino ester (±)-51.
To avoid E1cb elimination, a possible solution is to perform the heteroring opening before
the oxidative deselenylation and replacing the poor leaving group hydroxide with the acceptable
leaving group carbamate. Even in this case, it may be necessary to perform the oxidation under
acidic conditions (e.g.,  MCPBA  or  H2O2/CF3COOH [46]) instead of the basic conditions applied
above. These studies are currently in progress in our laboratory.
Conclusions
Using one-step redox-neutral isomerization of allylic alcohols into saturated ketones, we
significantly improved the synthesis of the cis and trans isomers of 3,3- and 5,5-difluorinated
2-aminocyclohexanecarboxylates. To expand this improved strategy, preparation of various β-
aminocycloalkanecarboxylates with an allylic alcohol motif was attempted using organoselenium
chemistry. Some key intermediates were prone to E1cb elimination and the desired allylic alcohol
products were not formed. Modification of the synthetic pathway to eliminate the source of the
problem is still ongoing. Further variations of the synthetic methods in view of the extension of the
methods to access geminal difluorinated scaffolds are currently under investigation.
Experimental
General information
Chemicals were purchased from Sigma-Aldrich. Solvents were used as received from the
suppliers. Melting points were determined with a Kofler apparatus. Elemental analyses were
performed with a Perkin–Elmer CHNS-2400 Ser II elemental analyser. Silica gel 60 F254 was
purchased from Merck. NMR spectra were acquired at room temperature on a Bruker Avance 400
spectrometer (1H frequency 400.13 MHz; 13C frequency 100.76 MHz) in CDCl3 or  D6-DMSO
solution, using the deuterium signal of the solvent to lock the field. The 1H and 13C chemical shifts
are given relative to TMS. β-Amino acid derivatives (±)-5-(±)-37, (±)-40, (±)-42, (±)-43 and (±)-51
are known compounds earlier described in the literature [22,23,26,38,48-50].
General procedure for Pd-catalyzed isomerization
To a solution of 1 mmol allylic alcohol in 10 ml EtOAc 15 mg Pd/C (10 wt %) was added.
The reaction mixture was stirred at 20 °C under hydrogen (1 bar) overnight. The reaction mixture
was then filtered on a fritted glass filter covered with Celite®. The filtrate was dried (Na2SO4) and
concentrated. The crude product was purified by column chromatography on silica gel
(n-hexane/EtOAc).
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General procedure for selenocyclizations
To a solution of 5 mmol β-amino ester in 25 ml MeCN 5 mmol PhSeBr was added and the
mixture was stirred at 20°C for 18 h. The progress of the reaction was monitored by TLC. After
completion, the reaction mixture was diluted with 60 ml EtOAc and washed with 2×20 ml saturated
aqueous NaHCO3 solution. The organic phase was dried (Na2SO4) and concentrated. The crude
product was crystallized from Et2O.
General procedure for N-Boc protection of selenocyclization products
2 Equiv Et3N, 1 equiv Boc2O, and 20 mol% DMAP were added to a solution of 1.5 g
selenocyclized compound in 30 ml THF at 0°C. The resulting mixture was allowed to warm up to
20°C and stirred for 6 h. Then, the reaction mixture was diluted with 70 ml EtOAc and washed with
3×30 ml water. The organic phase was dried (Na2SO4) and concentrated. The crude product was
purified by column chromatography on silica gel (n-hexane/EtOAc).
General procedure for oxidative deselenylation.
To a solution of 2 mmol phenylselenyl β-amino ester in 25 ml THF, 2 equiv NaHCO3, and
5 equiv H2O2 (as 30% aqueous solution) were added at 0°C. The mixture was allowed to warm up
to 20°C and stirred for 30 min. After adding 2.5 equiv Et3N stirring was continued for 14 h. Then
the reaction mixture was diluted with 90 mL EtOAc and washed with 2×20 ml water. The organic
phase was dried (Na2SO4) and concentrated. The crude product was purified by column
chromatography on silica gel (n-hexane/EtOAc).
Reaction of iodooxazolidinone (±)-30 with KOH/THF.
To a solution of 300 mg compound (±)-30 in 15 ml THF, 1 ml water, and 2 equiv KOH were
added and the mixture was stirred at 20°C for 28 h. Then the reaction mixture was diluted with
20 ml water and extracted with 3×10 ml CH2Cl2. The organic phase was dried (Na2SO4) and
concentrated. The crude product was purified by column chromatography on silica gel
(n-hexane/EtOAc).
General procedure for fluorination of keto-amino esters.
To a solution of amino ester (±)-10, (±)-11, (±)-22 or (±)-23 (1.5 mmol) in CH2Cl2 (15 ml)
one drop of EtOH was added followed by the dropwise addition of Deoxofluor (1.5 equiv, 50% in
toluene) at 0°C and stirring was continued at room temperature overnight. The mixture was then
Online journal “Fluorine notes” ISSN 2071-4807, Vol. 1(134), 2021; DOI: 10.17677/fn20714807.2021.01.03
diluted with CH2Cl2 (25 ml) and the organic phase was washed with an aqueous solution of
NaHCO3. The organic layer was dried over Na2SO4 and concentrated, and the crude product was
purified by column chromatography on silica gel (n-hexane-EtOAc 4:1).
X-ray crystallographic study of (±)-48.
Crystallographic data were collected at 123 K with a Nonius-Kappa CCD area detector
diffractometer, using graphite-monochromatized Mo-Ka radiation (l = 0.71073 Å) as reported
earlier [51]. The structure was solved by direct methods by use of the SHELXS-97 program [2] and
full-matrix, least-squares refinements on F2 were performed by use of the SHELXL-97 program
[52]. The CH hydrogen atoms were included at fixed distances from their host atoms with the fixed
displacement parameters. The ORTEP plot was drawn with ORTEP-3 for Windows [53]. The
deposition number CCDC 2051318 contain the supplementary crystallographic data for this paper.
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via
http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data
Centre, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: (internat.) + 44-1223-336-033; E-mail:
deposit@ccdc.cam.ac.uk)
Crystal data for (±)-48, C20H25NO6Se, Mr = 454.37, monoclinic, space group P21/c (no. 14), a =
9.1060(1), b = 18.8854(3), c = 11.8729(2) Å, a = 90, β = 90.73(1), d = 90∞, V = 2041.62(5) Å3, T =
123 K, Z = 4, μ(Mo-Kα) = 1.478 mm-1. Total 4450  refelections, unique 3973. Refinement of 4450
reflections (257 parameters) with I > 2d(I) converged at final R1 = 0.0236 ( R1 all data = 0.0289),
wR2 = 0.0553 (wR2 all data = 0.0575), GOF = 1.049.
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Characterization of the synthetized new substances
Ethyl (1R*,2R*,3R*,4S*)-2-((tert-butoxycarbonyl)amino)-3,4-dihydroxycyclopentane-1-
carboxylate.
White solid, yield: 52%. Mp. 55-57 °C (n-hexane/EtOAc), Rf = 0.4 (n-hexane/EtOAc 1:1).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.27 (t, J = 7.13 Hz, 3H, CH3), 1.46 (s, 9H, tBu), 1.91-2.01
(m, 1H, CH2), 2.62-2.72 (m, 1H, CH2), 2.73-2.82 (m, 1H, H-1), 3.41-3.47 (m, 1H, H-3), 3.51-3.56
(m, 1H, H-4), 4.06-4.22 (m, 2H, OCH2), 4.37-4.46 (m, 1H, H-2), 6.41 (d, J = 8.18 Hz, 1H, N-H).




Colorless oil, yield: 83%. Rf = 0.5 (n-hexane/EtOAc 1:2).
1H NMR (400 MHz, D6-DMSO): δ (ppm) = 1.24 (t, J = 7.8 Hz, 3H, CH3), 1.80-1.89 (m, 1H, CH2),
2.11-2.22 (m, 1H, CH2), 3.37-3.49 (m, 1H, H-4), 4.03-4.09 (m, 1H, H-6), 4.14 (q, J = 6.99 Hz, 2H,
OCH2), 5.02-5.10 (m, 2H, H-3a and H-6a), 7.35-7.43 (m, 3H, Ar-H), 7.43-7.50 (m, 2H, Ar-H),
7.52-7.59 (m, 1H, Ar-H), 7.60-7.67 (m, 2H, Ar-H), 7.75-7.82 (m, 2H, Ar-H).
13C NMR (100 MHz, D6-DMSO): δ (ppm) = 15.1, 31.1, 46.2, 49.2, 60.8, 73.2, 88.7, 127.5, 128.7,
128.9, 129.5, 129.9, 130.4, 132.6, 134.3, 163.5, 171.3.
Ethyl (3aR*,4R*,6R*,6aR*)-2-oxo-6-(phenylselanyl)hexahydro-2H-cyclopenta[d]oxazole-4-
carboxylate.
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White solid, yield: 62%. Mp. 143-144 °C (Et2O), Rf = 0.7 (n-hexane/EtOAc 1:3).
1H NMR (400 MHz, D6-DMSO): δ (ppm) = 1.22 (t, J = 7.07 3H, CH3), 1.84-1.95 (m, 1H, CH2),
2.31-2.44 (m, 1H, CH2), 3.18-3.29 (m, 1H, H-4), 3.96-4.21 (m, 3H, OCH2 and H-6), 4.53-4.61 (m,
1H, H-3a), 4.84-4.91 (m, 1H, H-6a), 7.33-7.42 (m, 3H, Ar-H), 7.53-7.62 (m, 2H, Ar-H), 7.92 (brs,
1H, N-H).
13C NMR (100 MHz, D6-DMSO): δ (ppm) = 14.8, 31.1, 45.3, 49.4, 57.9, 61.5, 85.2, 128.7, 129.3,
130.4, 134.0, 158.7, 171.1.
3-(tert-Butyl) 4-ethyl (3aR*,4R*,6R*,6aR*)-2-oxo-6-(phenylselanyl)tetrahydro-2H-
cyclopenta[d]oxazole-3,4(3aH)-dicarboxylate.
Colorless oil, yield: 98%. Rf = 0.6 (n-hexane/EtOAc 3:1).
1H NMR (400 MHz, CDCl3):  δ (ppm)  =  1.24  (t,  3H,  CH3), 1.50 (s, 9H, CH3), 2.12-2.20 (m, 1H,
CH2), 2.59-2.66 (m, 1H, CH2), 3.38-3.43 (m, 1H, H-4), 3.98-4.05 (m, 1H, H-6), 4.10-4.18 (m, 2H,
OCH2), 4.82-4.86 (m, 1H, H-3a), 4.99-5.05 (m, 1H, H-6a), 7.36-7.40 (m, 3H, Ar-H), 7.58-7.62 (m,
2H, Ar-H).
13C NMR (100 MHz, D6-DMSO): δ (ppm) = 14.7, 28.3, 34.8, 44.4, 47.4, 60.7, 61.5, 83.5, 83.7,
123.8, 128.9, 130.5, 134.4, 149.4, 151.5, 171.8.
Anal. calcd. (%) for C20H25NO6Se: C 52.87; H 5.55; N 3.08; found: C 52.91; H 5.58; N 3.04.
3-(tert-Butyl) 4-ethyl (3aR*,4R*,6aS*)-2-oxo-4,6a-dihydro-2H-cyclopenta[d]oxazole-3,4(3aH)-
dicarboxylate.
Online journal “Fluorine notes” ISSN 2071-4807, Vol. 1(134), 2021; DOI: 10.17677/fn20714807.2021.01.03
White solid, yield: 67%. Mp. 115-117 °C (n-hexane/Et2O), Rf = 0.40 (n-hexane/EtOAc 1:1).
1H NMR (400 MHz, CDCl3): δ = 1.26 (t, J = 7.15 Hz, 3H, CH3), 1.53 (s, 9H, CH3), 3.86-3.93 (m,
1H, H-4), 4.03-4.25 (m, 2H, OCH2), 4.86-4.94 (m, 1H, H-3a), 5.24-5.31 (m, 1H, H-6a), 6.09-6.17
(m, 2H, H-5 and H-6).
13C NMR (100 MHz, D6-DMSO): δ = 14.7, 28.3, 54.9, 58.2, 61.7, 81.3, 83.5, 131.3, 138.1, 140.2,
151.8, 170.4.
Anal. calcd. (%) for C14H19NO6: C 56.56; H 6.44; N 4.71; found: C 56.53; H 6.49; N 4.72.
Ethyl (3aR*,4S*,6R*,6aR*)-2-oxo-6-(phenylselanyl)hexahydro-2H-cyclopenta[d]oxazole-4-
carboxylate.
Colorless oil, yield: 60%. Rf = 0.65 (n-hexane/EtOAc 1:3).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.30 (t, J = 7.12 Hz, 3H, CH3), 2.17-2.33 (m, 1H, CH2),
2.55-2.68 (m, 1H, CH2), 2.80-2.88 (m, 1H, H-4), 3.74-3.84 (m, 1H, H-6), 4.21 (q, J = 7.14 Hz, 2H,
OCH2), 4.63-4.71 (m, 1H, H-3a), 4.92-5.00 (m, 1H, H-6a), 5.26 (brs, 1H, N-H), 7.28-7.36 (m, 3H,
Ar-H), 7.50-7.60 (m, 2H, Ar-H).
13C NMR (100 MHz, D6-DMSO): δ (ppm) = 14.9, 33.9, 45.7, 52.2, 59.1, 61.5, 85.8, 128.5, 129.6,
130.3, 133.9, 158.3, 172.8.
Anal. calcd. (%) for C15H17NO4Se: C 50.86; H 4.84; N 3.95; found: C 50.83; H 4.80; N 3.89.
3-(tert-Butyl) 4-ethyl (3aR*,4S*,6R*,6aR*)-2-oxo-6-(phenylselanyl)tetrahydro-2H-
cyclopenta[d]oxazole-3,4(3aH)-dicarboxylate.
White solid, yield: 86%. Mp. 107-108 °C (n-hexane/EtOAc), Rf = 0.65 (n-hexane/EtOAc 3:1).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.31 (t, J = 7.14 Hz, 3H, CH3), 1.51 (s, 9H, tBu), 2.22-2.33
(m, 1H, CH2), 2.52-2.66 (m, 1H, CH2), 2.94-3.03 (m, 1H, H-4), 3.73-3.81 (m, 1H, H-6), 4.15-4.30
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(m, 2H, OCH2), 4.76-4.84 (m, 1H, H-3a), 5.15-5.22 (m, 1H, H-6a), 7.27-7.35 (m, 3H, Ar-H),
7.48-7.57 (m, 2H, Ar-H).
13C NMR (100 MHz, CDCl3): δ (ppm) = 14.5, 28.4, 34.0, 45.3, 51.5, 61.9, 61.9, 83.0, 84.9, 128.2,
128.8, 129.9, 134.8, 149.2, 151.6, 172.2.
Anal. calcd. (%) for C20H25NO6Se: C 52.87; H 5.55; N 3.08; found: C 52.92; H 5.61; N 3.03.
3-(tert-Butyl) 4-ethyl (3aR*,4S*,6aS*)-2-oxo-4,6a-dihydro-2H-cyclopenta[d]oxazole-3,4(3aH)-
dicarboxylate.
White solid, yield: 63%. Mp. 96-99 °C (n-hexane/Et2O), Rf = 0.45 (n-hexane/EtOAc 1:1).
1H NMR (400 MHz, D6-DMSO): δ = 1.22 (t, J = 7.10 Hz, 3H, CH3), 1.45 (s, 9H, tBu), 3.88-3.94
(m, 1H, H-4), 4.06-4.21 (m, 2H, OCH2), 4.96-5.03 (m, 1H, H-3a), 5.51-5.59 (m, 1H, H-6a),
6.03-6.10 (m, 1H, H-5), 6.11-6.19 (m, 1H, H-6).
13C NMR (100 MHz, D6-DMSO): δ = 14.9, 28.4, 58.8, 59.7, 61.9, 81.9, 83.8, 131.3, 136.2, 149.2,
151.8, 171.5.
Anal. calcd. (%) for C14H19NO6: C 56.56; H 6.44; N 4.71; found: C 56.57; H 6.48; N 4.68.
Ethyl (1R*,5S*,6R*,8R*)-3-oxo-8-(phenylselanyl)-2-oxa-4-azabicyclo[3.3.1]nonane-6-
carboxylate.
White solid, yield: 69%. Mp. 105-106 °C (Et2O), Rf = 0.5 (n-hexane/EtOAc 1:3).
1H NMR (400  MHz,  D6-DMSO):  δ (ppm)  =  1.20  (t, J =  7.11  Hz,  3H,  CH3), 1.87-2.03 (m, 2H,
CH2), 2.10-2.30 (m, 2H, CH2), 2.78-2.89 (m, 1H, H-6), 3.81-3.88 (m, 1H, H-5), 3.88-3.94 (m, 1H,
H-8), 3.99-4.17 (m, 2H, OCH2), 4.47-4.55 (m, 1H, H-1), 7.32-7.40 (m, 3H, Ar-H), 7.55-7.64 (m,
3H, NH and Ar-H).
13C NMR (100 MHz, D6-DMSO): δ (ppm) = 14.8, 25.0, 26.3, 43.6, 43.7, 47.1, 61.3, 74.7, 128.8,
129.3, 130.5, 134.2, 153.4, 172.5.
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Colorless oil, yield: 92%. Rf = 0.5 (n-hexane/EtOAc 2:1).
1H NMR (400 MHz, CDCl3):  δ (ppm)  =  1.33  (t,  3H,  CH3), 1.54 (s, 9H, CH3), 2.01-2.13 (m, 2H,
CH2), 2.47-2.61 (m, 2H, CH2), 2.93-2.97 (m, 1H, H-6), 3.87-3.89 (m, 1H, H-8), 4.06-4.21 (m, 2H,
OCH2), 4.63-4.65 (m, 1H, H-5), 5.02-5.04 (m, 1H, H-1), 7.32-7.36 (m, 3H, Ar-H), 7.55-7.58 (m,
2H, Ar-H).
13C NMR (100 MHz, D6-DMSO): δ (ppm) = 14.7, 25.1, 26.5, 28.4, 42.5, 42.9, 51.0, 61.3, 76.1,
83.9, 128.9, 129.1, 130.5, 134.2, 148.5, 152.6, 172.3.
Anal. calcd. (%) for C21H27NO6Se: C 53.85; H 5.81; N 2.99; found: C 53.89; H 5.84; N 3.01.
Ethyl 6-((tert-butoxycarbonyl)amino)cyclohexa-1,3-diene-1-carboxylate.
White solid, yield: 55%. Mp. 105-107 °C (n-hexane/Et2O), Rf = 0.65 (n-hexane/EtOAc 3:1).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.30 (t, J =  7.12  Hz,  3H,  CH3), 1.43 (s, 9H, CH3),
2.42-2.54 (m, 1H, CH2), 2.66-2.77 (m, 1H, CH2), 4.16-4.33 (m, 2H, OCH2), 4.47-4.65 (brs, 1H, N-
H), 4.70-4.84 (m, 1H, H-6), 6.12-6.23 (m, 2H, H-3 and H-4), 7.14-7.21 (m, 1H, H-2).
13C NMR (100 MHz, D6-DMSO): δ (ppm) = 15.0, 29.1, 32.0, 41.1, 60.8, 78.4, 124.0, 126.5, 133.2,
135.8, 166.7, 170.5.
Anal. calcd. (%) for C14H21NO4: C 62.90; H 7.92; N 5.24; found: C 62.89; H 7.96; N 5.21.
Online journal “Fluorine notes” ISSN 2071-4807, Vol. 1(134), 2021; DOI: 10.17677/fn20714807.2021.01.03











































































Online journal “Fluorine notes” ISSN 2071-4807, Vol. 1(134), 2021; DOI: 10.17677/fn20714807.2021.01.03
Ethyl 6-((tert-butoxycarbonyl)amino)cyclohexa-1,3-diene-1-carboxylate.
CO2Et
NHBoc
(±)-55
